Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Bernie Sanders and congressional Democrats speak at a news conference about drug prices. Photo: Bill Clark/CQ Roll Call via Getty Images

Voters say pretty much everyone in Washington is dropping the ball on prescription drug prices, according to a new survey from the nonpartisan West Health Institute and NORC at the University of Chicago.

By the numbers: 50% of those surveyed said they disapprove of the way congressional Republicans are handling drug prices, compared with 46% disapproval for Trump and 43% for congressional Democrats.

  • 23% said they approve of President Trump’s approach to the issue, compared to 20% for Democrats and 16% for congressional Republicans.

Three specific policy proposals scored an approval rating of 80% or higher: direct Medicare price negotiations, more generics, and “requiring drug companies to release information to the public on how they set their drug prices.”

Echoing a slew of other polls, this survey also found that health care — and costs, specifically — is one of voters’ top concerns in the midterm elections.

Go deeper

Erica Pandey, author of @Work
5 mins ago - Economy & Business

Work-wherever turns to work-whenever

Illustration: Sarah Grillo/Axios

The pandemic killed the 9-to-5 workday for many.

The big picture: So much of our society — from after-school child care programs to the most coveted time slots for television shows — is structured around working from 9 to 5. But our countrywide experiment in remote work has demonstrated that the hours we are logged on don't matter as long as the work gets done.

Ben Geman, author of Generate
34 mins ago - Energy & Environment

Biden's plan to upend Trump's environmental legacy

Illustration: Aïda Amer/Axios. Photo by Brendan Smialowski/AFP via Getty Images

President-elect Joe Biden will on Wednesday order a government-wide review of over 100 Trump-era policies and direct agencies to prepare a suite of emissions and energy efficiency rules.

Why it matters: New information from transition officials offers the full scope of Biden's imminent, inauguration-day burst of environmental and energy policy moves.

Caitlin Owens, author of Vitals
35 mins ago - Health

The public health presidency

Illustration: Eniola Odetunde/Axios

Joe Biden will take office today facing a challenge none of his modern predecessors have had to reckon with — his legacy will depend largely on how well he handles a once-in-a-century pandemic that's already raging out of control.

The big picture: Public health tends to be relatively apolitical and non-controversial. The limelight in health care politics typically belongs instead to debates over costs and coverage. But that will all change for the Biden administration.